Focus:
Fujifilm Toyama Chemical has started a Phase III clinical trial of its antiviral influenza drug Avigan (favipiravir) for the treatment of Covid-19 patients in Japan.
Pluristem Therapeutics has started dosing Covid-19 patients in Israel with PLX cells under a compassionate use programme approved by the country’s health ministry.
Bellerophon Therapeutics has treated the first Covid-19 patient with its INOpulse at the University of Miami School of Medicine in the US.
Researchers at three institutions in the US and UK have received grants to advance trials of repurposed drugs and novel antibodies for the prevention of Covid-19.
I-Mab Biopharma has filed an investigational new drug (IND) application with South Korea’s Ministry of Food and Drug Safety (MFDS) to conduct a clinical trial of TJM2 for the treatment...
AI clinical analytics platform firm Saama Technologies has made its clinical analytics platform available to integrate data from all organisations engaged in the investigation of Covid-19 treatments.
AstraZeneca is set to stop the Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) early after the drug showed encouraging efficacy profile.
Researchers at the University of Oxford in the UK have commenced enrolment of healthy volunteers for a clinical trial of the Covid-19 vaccine candidate ChAdOx1 nCoV-19.
Sanofi has started a Phase II/III clinical trial of rheumatoid arthritis drug Kevzara (sarilumab) to treat patients hospitalised with severe Covid-19 infection outside of the US.
Biotechnology firm Moderna has provided update on the impact of the Covid-19 coronavirus pandemic on its clinical development activities and business operations.
